Pharmacist roles in the management of patients with type 2 diabetes

Sisson, Evan M.; Kuhn, Catherine

doi:10.1331/japha.2009.09075

Cited by 31 publications

(26 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Education and counseling are important for changes in behavior and lifestyle, such as self-care, nutrition counseling, program of physical exercises and quitting smoking (Nichols-English, Poirier, 2000;Berdine, O'Neil, 2007;Sisson, Kuhn, 2009;Maffeo et al, 2009;Lenz et al, 2011). (2) Follow-up or monitoring in order to detect the patient's non-adherence, and to recognize possible side effects (O'Loughlin et al, 1999;Chandra, Malcolm, Fetters, 2003;Grant et al, 2003).…”

Section: The Role Of the Pharmacistmentioning

confidence: 99%

Pharmaceutical services and health promotion: how far have we gone and how are we faring? Scientific output in pharmaceutical studies

Nakamura¹,

Soares²,

Farías³

et al. 2014

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

The objective of this study was to investigate the scientific output on health promotion within the pharmaceutical field and its relation with the development of pharmaceutical services within health systems. A comprehensive review of published scientific articles from the Medline and Lilacs databases was carried out. The review comprised articles published until December 2011, and used combinations of the terms 'health promotion' or 'health education' and 'pharmacy', 'pharmacist' or 'pharmaceutical'. The articles were selected according to inclusion and exclusion criteria. A total of 170 full texts and 87 indexed abstracts were analyzed, evidencing that most described actions of health promotion in community pharmacies and other services. Following the Ottawa Charter, most of the studies dealt with new guidance of the service and the supply of pharmaceutical information and services. It was concluded that there is a lack of theoretical background on health promotion in the pharmaceutical field to sustain the professional education and practice required by the health system and the population.Uniterms: Health promotion. Health education. Pharmaceutical care/scientific production. Pharmacists/ professional practice. Pharmacy.O objetivo do estudo foi investigar a produção científica sobre o desenvolvimento teórico e prático da promoção da saúde na farmácia e sua relação com o desenvolvimento da área e dos serviços farmacêuticos. A revisão integrativa de artigos científicos foi realizada a partir das bases de dados Medline e Lilacs. Ela compreendeu os artigos publicados até dezembro de 2011, através da combinação dos termos 'promoção da saúde ou educação em saúde' e 'farmácia, farmacêutico ou farmacêutica'. Critérios de inclusão e exclusão definiram a seleção dos textos. Ao todo, 170 artigos e 87 resumos foram analisados, sendo a maioria identificada como trabalhos teóricos que relatam atividades descritas como de promoção da saúde em farmácias comunitárias ou outros serviços. Confrontando com o referencial da Carta de Ottawa, a maioria dos estudos revelou ter como campo de investigação principal alguma proposição de reorientação dos serviços de saúde e oferta de informações e práticas farmacêuticas. Conclui-se que há uma carência de embasamento teórico sobre promoção da saúde na área farmacêutica para sustentar a formação e prática profissional, conforme exigido pelo sistema de saúde e pela população.Unitermos: Promoção da saúde. Educação em saúde. Atenção farmacêutica/produção científica. Farmacêuticos/prática profissional. Farmácia.

show abstract

Section: The Role Of the Pharmacistmentioning

confidence: 99%

Pharmaceutical services and health promotion: how far have we gone and how are we faring? Scientific output in pharmaceutical studies

Nakamura¹,

Soares²,

Farías³

et al. 2014

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

show abstract

“…7,15 Furthermore, clinical pharmacists, with their pharmacotherapeutic knowledge and patient centered training, are uniquely positioned to educate, elaborate, implement and monitor patients on medication therapies, which ultimately results in better health outcomes. 7,[16][17][18] Cognizant of the global paradigm shift in pharmaceutical education and practice, Public universities in Ethiopian revised their undergraduate pharmacy curriculum in 2008 to be more patient focused and a limited number of pharmacy schools also started a postgraduate course in clinical pharmacy. Even though there has been an increase in pharmacists' involvement in patient care in Ethiopia, their full potential and role in clinical practice is yet to be explored.…”

Section: Original Researchmentioning

confidence: 99%

The Impact of Pharmacist-LED Medication Therapy Management on Medication Adherence in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study

et al. 2017

View full text Add to dashboard Cite

“…Given the pharmacist's expert pharmacologic and therapeutic knowledge, and roles as a disease educator, coach, and direct-care provider, pharmacists are uniquely positioned to determine treatment adherence, therapy response, and the potential drug therapy changes needed to meet patients' goals. 55 In patients who are not candidates for newer agents and who require insulin, the pharmacist's knowledge of the pharmacokinetics of insulins will be beneficial toward developing an optimal treatment plan using basal or basal-bolus therapy. As therapies are combined, pharmacists are well-positioned to counsel patients on recognizing and managing symptoms of hypoglycemia and encouraging them to discuss such symptoms with their health care provider.…”

Section: Role Of the Pharmacistmentioning

confidence: 99%

Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus

Goldman

2011

Pharmacotherapy

View full text Add to dashboard Cite

The majority of patients with type 2 diabetes mellitus will eventually require combination therapy involving two or more agents to achieve their glycemic target as their disease progresses. This review contrasts current treatment guidelines and recommendations by the American Diabetes Association and the European Association for the Study of Diabetes (referred to as ADA) and the American Association of Clinical Endocrinologists and American College of Endocrinology (referred to as AACE) for the initiation of combination therapy. Both treatment guidelines emphasize that treatment selection for patients with type 2 diabetes should be guided by the goal of lowering hemoglobin A(1c) (A1C) level and individualizing therapy to each patient based on clinical factors and comorbidities. In addition, combination therapy should include classes of drugs with complementary mechanisms of action that efficiently and effectively target the underlying type 2 diabetes pathophysiology. Both the ADA and AACE recommend metformin as a firstline oral agent; however, the ADA supports early use of sulfonylureas or insulin in patients who do not reach their target A1C goal, whereas the AACE recommends earlier and more frequent use of the newer incretin agents-glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Mechanisms of action, benefits, and risks of traditional and newer agents are discussed to better enable the pharmacist to recommend the best combinations of agents for individual patients.

show abstract

Pharmacist roles in the management of patients with type 2 diabetes

Cited by 31 publications

References 27 publications

Pharmaceutical services and health promotion: how far have we gone and how are we faring? Scientific output in pharmaceutical studies

Pharmaceutical services and health promotion: how far have we gone and how are we faring? Scientific output in pharmaceutical studies

The Impact of Pharmacist-LED Medication Therapy Management on Medication Adherence in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study

Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus

Contact Info

Product

Resources

About